Exogenus developed a sustainable analytical panel
Researchers at Exogenus implemented a sustainable assay panel to manage the high variability of umbilical cord blood as raw material. The workflow enables producing non-conventional EV products without compromising quality control.
- Field
- tools and releases
- What they did
- Exogenus Therapeutics developed a simplified and sustainable assay panel for quality control of extracellular vesicle (EV) production derived from umbilical cord blood.
- Why it matters
- This enables companies to produce products using non-standard cell sources while maintaining quality control and avoiding complex screening methods.
#extracellular vesicles#quality control#umbilical cord blood#exogenus therapeutics



